Track the companies that matter to you. It's FREE! Click one of these fan favorites to get started: Apple; Google; Ford.

Recs

0

Thoratec Shares Plunged: What You Need to Know

Don't let it get away!

Keep track of the stocks that matter to you.

Help yourself with the Fool's FREE and easy new watchlist service today.

Although we don't believe in timing the market or panicking over market movements, we do like to keep an eye on big changes -- just in case they're material to our investing thesis.

What: Shares of Thoratec (Nasdaq: THOR  ) , whose devices aid with circulation, fell more than 15% after management reduced its full-year outlook. The stock closed off 12.7%.

So what: Third-quarter revenue grew 13% but came up short of expectations. Adjusted earnings improved 28% to $0.41 a share, well above Wall Street's $0.34-per-share target, but weak sales weighed on 2011 guidance. Thoratec now expects sales to come in between $418 million to $423 million this year, down from earlier estimates of $422 million to $430 million.

Now what: Though the miss and decline must to be disappointing to some, the stock has to be nearing an attractive entry point for the equity analysts at Canaccord Genuity. They list Thoratec alongside AtriCure (Nasdaq: ATRC  ) and Volcano (Nasdaq: VOLC  ) , among others, as a likely buyout candidate. Do you agree? Would you buy shares of Thoratec at current prices? Please weigh in using the comments box below.

Interested in more information about Thoratec? Add it to your watchlist.

Fool contributor Tim Beyers is a member of the Motley Fool Rule Breakers stock-picking team. He didn't own shares in any of the companies mentioned in this article at the time of publication. Check out Tim's portfolio holdings and Foolish writings, or connect with him on Google+ or Twitter, where he goes by @milehighfool. You can also get his insights delivered directly to your RSS reader.

Motley Fool newsletter services have recommended buying shares of Volcano. Try any of our Foolish newsletter services free for 30 days. We Fools don't all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.


Read/Post Comments (0) | Recommend This Article (0)

Comments from our Foolish Readers

Help us keep this a respectfully Foolish area! This is a place for our readers to discuss, debate, and learn more about the Foolish investing topic you read about above. Help us keep it clean and safe. If you believe a comment is abusive or otherwise violates our Fool's Rules, please report it via the Report this Comment Report this Comment icon found on every comment.

Be the first one to comment on this article.

Sponsored Links

Leaked: Apple's Next Smart Device
(Warning, it may shock you)
The secret is out... experts are predicting 458 million of these types of devices will be sold per year. 1 hyper-growth company stands to rake in maximum profit - and it's NOT Apple. Show me Apple's new smart gizmo!

DocumentId: 1582727, ~/Articles/ArticleHandler.aspx, 7/30/2015 8:08:31 AM

Report This Comment

Use this area to report a comment that you believe is in violation of the community guidelines. Our team will review the entry and take any appropriate action.

Sending report...

Tim Beyers
TMFMileHigh

Tim Beyers first began writing for the Fool in 2003. Today, he's an analyst for Motley Fool Rule Breakers and Motley Fool Supernova. At Fool.com, he covers disruptive ideas in technology and entertainment, though you'll most often find him writing and talking about the business of comics. Find him online at timbeyers.me or send email to tbeyers@fool.com. For more insights, follow Tim on Google+ and Twitter.

Today's Market

updated 10 hours ago Sponsored by:
DOW 17,751.39 121.12 0.69%
S&P 500 2,108.57 15.32 0.73%
NASD 5,111.73 0.00 0.00%

Create My Watchlist

Go to My Watchlist

You don't seem to be following any stocks yet!

Better investing starts with a watchlist. Now you can create a personalized watchlist and get immediate access to the personalized information you need to make successful investing decisions.

Data delayed up to 5 minutes

Related Tickers

7/29/2015 3:59 PM
ATRC $26.68 Up +3.44 +14.80%
AtriCure, Inc. CAPS Rating: **
THOR $63.13 Up +0.03 +0.05%
Thoratec Corp CAPS Rating: ****
VOLC $0.00 Down +0.00 +0.00%
Volcano CAPS Rating: **

Advertisement